Eve & Co Incorporated (EEVVF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Eve & Co Incorporated (EEVVF) trades at $0.08 with AI Score 38/100 (Grade D). Eve & Co Incorporated focuses on the production and sale of cannabis products in Canada, primarily targeting the women's market. Market cap: $2.86M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for EEVVF: EEVVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EEVVF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
EEVVF: 1/1 perspectives are bearish.
How is this calculated? →Eve & Co Incorporated (EEVVF) Healthcare & Pipeline Overview
Eve & Co Incorporated, operating through Natural MedCo Ltd., cultivates and distributes cannabis products in Canada, focusing on the women's market with its EVE brand. Facing negative profit and gross margins, the company navigates a competitive landscape in the specialty and generic drug manufacturing sector.
What Is the Investment Thesis for EEVVF?
Investing in Eve & Co Incorporated (EEVVF) presents a high-risk, high-reward scenario. The company's focus on the women's cannabis market offers a unique selling proposition, but its current financial metrics raise concerns. With a negative profit margin of -287.9% and a negative gross margin of -79.6%, the company's ability to achieve profitability is uncertain. Potential investors should closely monitor the company's efforts to improve operational efficiency and expand its market share. Upcoming catalysts include potential regulatory changes in the Canadian cannabis market and the introduction of new product lines. However, ongoing risks include intense competition and the company's ability to secure additional funding.
Based on FMP financials and quantitative analysis
EEVVF Key Highlights
- Market Cap of $2.86M indicates the company's small size and limited market valuation.
- P/E Ratio of -0.29 reflects the company's current lack of profitability.
- Profit Margin of -287.9% highlights significant losses and operational inefficiencies.
- Gross Margin of -79.6% indicates that the company's cost of goods sold exceeds its revenue.
- Beta of 0.60 suggests that the stock is less volatile than the overall market.
Who Are EEVVF's Competitors?
EEVVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EEVVF's Key Strengths?
- Focus on the women's cannabis market.
- Established cultivation and production facility.
- EVE brand recognition.
- Compliance with Canadian cannabis regulations.
What Are EEVVF's Weaknesses?
- Negative profit and gross margins.
- Limited market share compared to larger competitors.
- Dependence on the Canadian cannabis market.
- OTC listing indicates higher risk.
What Could Drive EEVVF Stock Higher?
- Potential changes in Canadian cannabis regulations that could benefit the company.
- Introduction of new cannabis-infused product lines targeting the women's market.
- Expansion of distribution channels through partnerships with retailers.
- Efforts to improve operational efficiency and reduce production costs.
- Marketing campaigns to increase brand awareness and customer loyalty.
What Are the Key Risks for EEVVF?
- Negative return on equity (-36.9%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the Canadian cannabis market.
- Fluctuations in cannabis prices and demand.
- Regulatory changes that could negatively impact the company's operations.
- The company's negative profit and gross margins.
- Difficulty securing additional funding to support growth initiatives.
What Are the Growth Opportunities for EEVVF?
- Expansion into New Product Lines: Eve & Co can expand its product offerings to include cannabis-infused edibles, beverages, and topicals, catering to a broader range of consumer preferences. The market for cannabis-infused products is growing rapidly, with a projected market size of $4 billion in Canada by 2028. This expansion could attract new customers and increase revenue streams, providing a significant growth opportunity for the company. Success depends on regulatory approvals and effective product development.
- Strategic Partnerships and Acquisitions: Eve & Co can pursue strategic partnerships or acquisitions to expand its market reach and product portfolio. Collaborating with established cannabis companies or acquiring smaller, innovative brands can provide access to new technologies, distribution networks, and customer bases. The Canadian cannabis market is consolidating, creating opportunities for strategic alliances. These partnerships could enhance Eve & Co's competitive position and drive revenue growth.
- Focus on International Markets: Eve & Co can explore opportunities to export its cannabis products to international markets, particularly those with legal cannabis frameworks. The global cannabis market is expanding, with increasing demand in Europe, Latin America, and other regions. Exporting cannabis products can diversify revenue streams and reduce reliance on the Canadian market. However, navigating international regulations and establishing distribution channels will be critical for success.
- Development of Proprietary Cannabis Strains: Investing in research and development to create unique and proprietary cannabis strains can provide Eve & Co with a competitive advantage. Developing strains with specific cannabinoid profiles and therapeutic effects can attract customers seeking targeted health and wellness benefits. Proprietary strains can also command higher prices and improve profit margins. This requires significant investment in research and development, but the potential returns are substantial.
- Enhancement of Online Sales and Marketing: Improving the company's online sales platform and digital marketing strategies can enhance customer engagement and drive revenue growth. Investing in e-commerce capabilities, search engine optimization, and social media marketing can increase brand awareness and attract online customers. The online cannabis market is growing rapidly, providing a convenient and accessible channel for consumers. Effective online marketing can differentiate Eve & Co from competitors and drive sales.
What Opportunities Does EEVVF Have?
- Expansion into new product lines (edibles, beverages).
- Strategic partnerships and acquisitions.
- International market expansion.
- Development of proprietary cannabis strains.
What Threats Does EEVVF Face?
- Intense competition in the Canadian cannabis market.
- Evolving cannabis regulations.
- Fluctuations in cannabis prices.
- Potential for oversupply in the market.
What Are EEVVF's Competitive Advantages?
- Brand recognition in the women's cannabis market.
- Established cultivation and production infrastructure.
- Proprietary strains and product formulations.
- Strategic focus on a specific demographic segment.
What Does EEVVF Do?
Eve & Co Incorporated, headquartered in Strathroy, Canada, operates through its subsidiary, Natural MedCo Ltd., to produce and sell cannabis products. The company distinguishes itself by focusing on the women's market with its EVE brand, offering a range of products including dried cannabis, cannabis plants, and cannabis oil. Since its inception, Eve & Co has aimed to establish a strong presence in the Canadian cannabis industry by catering to specific demographic needs. The company's cultivation and production processes are designed to meet the regulatory standards of Health Canada, ensuring product quality and compliance. Eve & Co's strategic focus on the women's market is intended to differentiate it from competitors in the broader cannabis market. However, the company faces challenges related to profitability, as indicated by its negative profit and gross margins. The company continues to navigate the evolving regulatory landscape and competitive dynamics of the Canadian cannabis market, seeking opportunities for growth and improved financial performance.
What Products and Services Does EEVVF Offer?
- Produces dried cannabis for recreational and medicinal use.
- Cultivates cannabis plants for sale to consumers and other producers.
- Extracts cannabis oil for use in various products.
- Offers cannabis products specifically targeted towards women under the EVE brand.
- Operates a cultivation facility in Strathroy, Canada.
- Distributes cannabis products through authorized retailers and online channels.
How Does EEVVF Make Money?
- Cultivates and processes cannabis at its facility.
- Sells dried cannabis, plants, and oil to retailers and consumers.
- Focuses on the women's market with specialized branding and products.
What Industry Does EEVVF Operate In?
Eve & Co Incorporated operates within the Canadian cannabis industry, which has experienced significant growth since legalization but also faces intense competition and regulatory challenges. The market includes both large, established players and smaller, niche-focused companies like Eve & Co. The industry is subject to evolving regulations, including those related to production, distribution, and marketing. Companies must navigate these regulations while also competing on product quality, branding, and pricing. The Canadian cannabis market is projected to continue growing, driven by increasing consumer acceptance and the expansion of legal channels.
Who Are EEVVF's Key Customers?
- Recreational cannabis users in Canada.
- Medicinal cannabis patients with prescriptions.
- Retailers and distributors of cannabis products.
- Women seeking cannabis products tailored to their needs.
EEVVF Valuation & Market Position
With a $2.86M market cap, Eve & Co Incorporated sits in the micro-cap segment of the market. Relative to its peer group, EEVVF's quantitative score of 38/100 is below the peer average of 66/100.
ROE -37%Key Financial Metrics
Return on equity for Eve & Co Incorporated stands at -36.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -19.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.42 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
Eve & Co Incorporated's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 72.75 places it in the safe zone, indicating low near-term bankruptcy risk.
EEVVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Focus on the women's cannabis market.
- Established cultivation and production facility.
- EVE brand recognition.
- Compliance with Canadian cannabis regulations.
Bear Case
- Negative profit and gross margins.
- Limited market share compared to larger competitors.
- Dependence on the Canadian cannabis market.
- OTC listing indicates higher risk.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
EEVVF Latest News
No recent news available for EEVVF.
EEVVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EEVVF.
Price Targets
Wall Street price target analysis for EEVVF.
EEVVF MoonshotScore
What does this score mean?
The MoonshotScore rates EEVVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Melinda Rombouts
CEO
Melinda Rombouts is the CEO of Eve & Co Incorporated. Her background includes experience in the cannabis industry, with a focus on cultivation, production, and branding. She has been involved in the development and implementation of Eve & Co's strategic initiatives, including its focus on the women's market. Her expertise spans regulatory compliance, product development, and market expansion within the Canadian cannabis sector. She has also worked to establish partnerships and collaborations to enhance the company's growth prospects.
Track Record: Under Melinda Rombouts' leadership, Eve & Co has focused on establishing its brand presence in the women's cannabis market. Key milestones include the launch of the EVE brand and the expansion of the company's product offerings. She has also overseen the company's efforts to comply with evolving cannabis regulations and optimize its cultivation and production processes. However, the company continues to face challenges related to profitability and market competition.
EEVVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Eve & Co Incorporated may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries higher risks compared to those listed on major exchanges like the NYSE or NASDAQ, due to the potential for less transparency and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Lower trading volumes and wider bid-ask spreads.
- Potential for increased price volatility.
- Higher risk of fraud or manipulation compared to major exchanges.
- Dependence on the Canadian cannabis market and regulatory environment.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's competitive position in the Canadian cannabis market.
- Review the company's compliance with cannabis regulations.
- Analyze the company's cash flow and debt levels.
- Monitor the company's news releases and investor presentations.
- Consult with a financial advisor before investing.
- Operation of a cultivation facility in Strathroy, Canada.
- Focus on the women's cannabis market with the EVE brand.
- Compliance with Canadian cannabis regulations.
- Presence in the Canadian cannabis market since its inception.
- CEO with experience in the cannabis industry.
Common Questions About EEVVF (Healthcare)
What does Eve & Co Incorporated do?
Eve & Co Incorporated, through its subsidiary Natural MedCo Ltd., cultivates, produces, and sells cannabis products in Canada. The company distinguishes itself by focusing on the women's market with its EVE brand, offering dried cannabis, cannabis plants, and cannabis oil. Eve & Co operates a cultivation facility in Strathroy, Canada, and distributes its products through authorized retailers and online channels. The company aims to establish a strong presence in the Canadian cannabis industry by catering to the specific needs and preferences of female consumers.
What do analysts say about EEVVF stock?
Analyst coverage of Eve & Co Incorporated (EEVVF) is limited due to its OTC listing and small market capitalization. Key valuation metrics, such as the P/E ratio, are currently negative, reflecting the company's lack of profitability. Growth considerations include the company's ability to expand its market share, improve its operational efficiency, and navigate the evolving regulatory landscape. Investors should conduct their own thorough research and consider the risks associated with investing in a small, OTC-listed cannabis company.
What are the main risks for EEVVF?
The main risks for Eve & Co Incorporated include intense competition in the Canadian cannabis market, fluctuations in cannabis prices and demand, and regulatory changes that could negatively impact the company's operations. The company's negative profit and gross margins also pose a significant risk, as they indicate potential financial instability. Additionally, the company's OTC listing and limited financial disclosure increase the risk for potential investors. Investors should carefully consider these risks before investing in EEVVF.
What are the key factors to evaluate for EEVVF?
Eve & Co Incorporated (EEVVF) holds an AI score of 38/100 (low). Not financial advice.
How frequently does EEVVF data refresh on this page?
EEVVF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven EEVVF's recent stock price performance?
Eve & Co Incorporated (EEVVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on the women's cannabis market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EEVVF overvalued or undervalued right now?
Valuing Eve & Co Incorporated (EEVVF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying EEVVF?
Before investing in Eve & Co Incorporated (EEVVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information and may be limited.
- OTC market data may not be as reliable as data from major exchanges.
- Analyst coverage is limited due to the company's size and OTC listing.